by Brigham and Women’s Hospital Credit: Unsplash/CC0 Public Domain Heart disease is the leading cause of death worldwide, killing someone in the United States every 34 seconds, according to the Centers for Disease Control and Prevention. A new study by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham health...
Mitchel L. Zoler, PhD February 23, 2023 The race-free, creatinine-based equation for calculating estimated glomerular filtration rate (eGFR), introduced in 2021 and gaining traction as the default tool for assessing kidney function in routine US practice, is expected to identify about 434,000 new cases of chronic kidney disease (CKD) among Black adults. At the same time, use of...
Anne L. Peters, MD February 03, 2023 Last week, a number of patients emailed me regarding their concerns about this phenomenon known as Ozempic face. I went on to read about what this meant. I live in Los Angeles, where most people appear to be on semaglutide (Ozempic). It’s the phenomenon where people lose weight relatively rapidly, making their...
According to a national registry, half of Medicare patients who underwent a procedure for symptom relief as it relates to lower extremity peripheral vascular disease did not receive the recommended medical therapy for long-term cardiovascular risk management. First author Kim G. Smolderen, PhD, MSc, and senior author Carlos Mena-Hurtado, MD, co-directors of the vascular medicine outcomes group at Yale, evaluated the...
by Julie Pacorel Videos under the hashtag #Ozempic have nearly 600 million views on TikTok. The diabetes drug Ozempic has become a social media phenomenon for its weight loss properties, but its soaring popularity has led to global shortages and doctors warn about the potential side effects. Videos under the hashtag #Ozempic have nearly 600...
by Brittany Phillips, University of North Carolina at Chapel Hill School of Medicine Credit: Unsplash/CC0 Public Domain A four-year clinical trial led by Edwin Kim, MD, at the UNC School of Medicine, has found that an increased dosage of a unique type of peanut allergy immunotherapy continues to show promise for children. A four-year phase 2 clinical trial demonstrated...
by Lori Solomon Pegcetacoplan (SYFOVRE) has been approved by the U.S. Food and Drug Administration as the first and only treatment for geographic atrophy (GA), an advanced form of age-related macular degeneration. Pegcetacoplan is an injection approved for GA patients with or without subfoveal involvement and allows a flexible dosing regimen of every 25 to...
by Bob Yirka, Medical Xpress SHAP interaction plot for depression, insomnia, and anxiety. Users with lower depression pre-symptom severity are more likely to benefit from cannabis use than users with higher pre-symptom severity of depression. Users with lower insomnia pre-symptom severity are less likely to benefit from cannabis use than users with higher pre-symptom severity...
BY QUINN PHILLIPS | FEBRUARY 23, 2023 Dexcom G7 family of products (Photo courtesy of Dexcom) Announced to the world last week with great fanfare in a Super Bowl commercial, the new Dexcom G7 continuous glucose monitoring (CGM) system includes several improvements over the previous model and will be covered for U.S. Medicare beneficiaries, according to...
Our eyes are never at rest. Instead, they remain in motion, even between our voluntary gaze shifts, through fixational eye movements—small, continuous movements of the eye that we are not aware of making. Scientists have long sought to understand how we humans can perceive the world as stable as our eyes are constantly moving. Past research...
